Hyperdynamic circulation in cirrhosis: A historical perspective
1994; Lippincott Williams & Wilkins; Volume: 20; Issue: 5 Linguagem: Inglês
10.1002/hep.1840200537
ISSN1527-3350
Autores Tópico(s)Liver Disease Diagnosis and Treatment
ResumoHepatologyVolume 20, Issue 5 p. 1356-1358 EditorialFree Access Hyperdynamic circulation in cirrhosis: A historical perspective Walter H. Abelmann M.D., Corresponding Author Walter H. Abelmann M.D. Cardiovascular Division Department of Medicine Beth Israel Hospital Boston, Massachusetts 02215Cardiovascular Division, Beth Israel Hospital, 330 Brookline Avenue, Boston, MA 02115===Search for more papers by this author Walter H. Abelmann M.D., Corresponding Author Walter H. Abelmann M.D. Cardiovascular Division Department of Medicine Beth Israel Hospital Boston, Massachusetts 02215Cardiovascular Division, Beth Israel Hospital, 330 Brookline Avenue, Boston, MA 02115===Search for more papers by this author First published: November 1994 https://doi.org/10.1002/hep.1840200537Citations: 59AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Kowalski HJ, Abelmann WH. The cardiac output at rest in Laënnec's cirrhosis. J Clin Invest 1953; 32: 1025–1033. 10.1172/JCI102813 PubMedWeb of Science®Google Scholar 2 Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958; 24: 358–367. 10.1016/0002-9343(58)90322-X CASPubMedWeb of Science®Google Scholar 3 Dock W. Present concepts regarding the mechanism of heart failure. Bull St Francis Sanatorium 1951; 8: No. 3, 1–15. Google Scholar 4 Kontos HA, Shapiro W, Mauck HP, Patterson JL. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964; 37: 526–535. 10.1016/0002-9343(64)90066-X PubMedWeb of Science®Google Scholar 5 Paton A, Thompson JW. Cirrhotic heart failure. BMJ 1961; 1: 179–181. 10.1136/bmj.1.5220.179 CASPubMedWeb of Science®Google Scholar 6 Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM, Cobos MA, Rodriguez-Eire JL, Garcia-Plaza A, et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 1989; 97: 1304–1312. 10.1016/0016-5085(89)91704-6 PubMedWeb of Science®Google Scholar 7 Maroto A, Ginès P, Arroyo V, Ginès A, Saló J, Clària J, Jiménez W, et al. Brachial and femoral artery flow in cirrhosis: relationship to kidney dysfunction. Hepatology 1993; 17: 788–793. 10.1002/hep.1840170507 PubMedWeb of Science®Google Scholar 8 Limas CJ, Guiha NH, Lekagul O, Cohn JN. Impaired left ventricular function in alcoholic cirrhosis with ascites: ineffectiveness of ouabain. Circulation 1974; 49: 855–760. 10.1161/01.CIR.49.4.755 Google Scholar 9 Shorr E, Zweifach BW. Hepato-renal factors in circulatory homeostasis. XIX. VEM and VDM mechanisms in nutritional cirrhosis in rats. Fed Proc 1948; 7: 115. Google Scholar 10 Hunt S, Vaamonde CA, Rattassi T, Berian G, Said SI, Papper S. Circulating levels of vasoactive intestinal polypeptide in liver disease. Arch Intern Med 1979; 139: 994–996. 10.1001/archinte.139.9.994 PubMedWeb of Science®Google Scholar 11 Sitzmann JV, Bulkley GB, Mitchell MC, Campbell K. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension. Ann Surg 1989; 209: 322–327. 10.1097/00000658-198903000-00012 PubMedWeb of Science®Google Scholar 12 Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988; 8: 232–236. 10.1002/hep.1840080207 CASPubMedWeb of Science®Google Scholar 13 Triger DR, Boyer TD, Levin J. Portal and systemic bacteremia and endotoxaemia in liver disease. Gut 1978; 19: 935–939. 10.1136/gut.19.10.935 CASPubMedWeb of Science®Google Scholar 14 Benoit JN, Barrowman JA, Harper SL, Kvietys PR, Granger DN. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. Am J Physiol 1984; 247: G484–G493. Google Scholar 15 Lee SS, Moreau R, Hadengue A, Cerini R, Koshy A, Lebrec D. Glucagon selectively increases splanchnic blood flow in patients with well-compensated cirrhosis. Hepatology 1988; 8: 1501–1505. 10.1002/hep.1840080606 PubMedWeb of Science®Google Scholar 16 Clària J, Jiménez W, Ros J, Asbert M, Castro A, Arroyo V, Rivera F, et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992; 15: 343–349. 10.1002/hep.1840150227 CASPubMedWeb of Science®Google Scholar 17 Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103: 1928–1949. 10.1016/0016-5085(92)91454-C CASPubMedWeb of Science®Google Scholar 18 Hörtnagl H, Singer EA, Lenz K, Kleinberger G, Lochs H. Substance P is markedly increased in plasma of patients with hepatic coma. Lancet 1984; 1: 480–483. 10.1016/S0140-6736(84)92851-4 PubMedWeb of Science®Google Scholar 19 Benoit JN, Granger DN. Splanchnic hemodynamics in chronic portal venous hypertension. Semin Liver Dis 1986; 6: 287–298. 10.1055/s-2008-1040611 PubMedWeb of Science®Google Scholar 20 Kravetz D, Arderium M, Bosch J, Fuster J, Visa J, Casamitjana R, Rodés J. Hyperglucagonemia and hyperkinetic circulation after portocaval shunt in the rat. Am J Physiol 1987; 252: G257–G261. CASPubMedGoogle Scholar 21 Rydell R, Hoffbauer FW. Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. Am J Med 1956; 21: 450–460. 10.1016/0002-9343(56)90043-2 PubMedWeb of Science®Google Scholar 22 Hansoti RC, Shah NJ. Cirrhosis of liver simulating congenital cyanotic heart disease. Circulation 1966; 33: 71–77. 10.1161/01.CIR.33.1.71 CASPubMedWeb of Science®Google Scholar 23 Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver: lung spider nevi. N Engl J Med 1966; 274: 291–298. 10.1056/NEJM196602102740601 CASPubMedWeb of Science®Google Scholar 24 Huet PM, Goreski LA, Villeneuve JP, Marleau D, Lough JO. Assessment of liver microcirculation in human cirrhosis. J Clin Invest 1982; 70: 1234–1244. 10.1172/JCI110722 CASPubMedWeb of Science®Google Scholar 25 Calabresi P, Abelmann WH. Porto-caval and porto-pulmonary anastomoses in Laënnec's cirrhosis and in heart failure. J Clin Invest 1957; 36: 1257–1265. 10.1172/JCI103523 CASPubMedWeb of Science®Google Scholar 26 Lebrec D, Bataille C, Bercoff E, Valla D. Hemodynamic changes in patients with portal venous obstruction. Hepatology 1983; 3: 550–553. 10.1002/hep.1840030412 PubMedWeb of Science®Google Scholar 27 Flückiger M. Vorkommen von trommelschlägelförmigen Fingerendphalangen ohne chronische Veränderungen an den Lungen oder am Herzen. Wien Med Wochenschr 1884; 34: 1457. Google Scholar 28 Keys A, Snell AM. Respiratory properties of the arterial blood in normal man and in patients with disease of the liver: position of the oxygen dissociation curve. J Clin Invest 1938; 17: 59–67. 10.1172/JCI100928 CASPubMedWeb of Science®Google Scholar 29 Abelmann WH, Kramer GE, Verstraeten JM, Gravallese MA, McNeely WG. Cirrhosis of the liver and decreased arterial oxygen saturation. Arch Intern Med 1961; 108: 34–40. 10.1001/archinte.1961.03620070036005 CASPubMedWeb of Science®Google Scholar 30 Fritts HW. Systemic circulatory adjustments in hepatic disease. Med Clin North Am 1963; 47: 563–578. PubMedWeb of Science®Google Scholar 31 Henriksen JH, Ring-Larsen H, Christensen NJ. Sympathetic nervous activity in cirrhosis: a survey of plasma catecholamine studies. Hepatology 1985; 1: 55–65. 10.1016/S0168-8278(85)80068-4 PubMedWeb of Science®Google Scholar 32 Lewis FW, Adair O, Rector WG Jr. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992; 102: 1024–1029. 10.1016/0016-5085(92)90192-2 CASPubMedWeb of Science®Google Scholar 33 Groszmann RJ. Hyperdynamic state in chronic liver diseases. J Hepatology 1993; 17(suppl 2): S38–S40. 10.1016/S0168-8278(05)80454-4 PubMedWeb of Science®Google Scholar 34 Katsuta Y, Aramaki T, Sekiyama T, Satomura K, Okumura K. Plasma volume contraction in portal hypertension. J Hepatol 1993; 17(suppl 2): S19–S23. 10.1016/S0168-8278(05)80450-7 PubMedWeb of Science®Google Scholar 35 Bateman JC, Shorr HM, Elgvin T. Hypervolumic anemia in cirrhosis. J Clin Invest 1948; 28: 539–547. 10.1172/JCI102102 Web of Science®Google Scholar 36 Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151–1157. 10.1002/hep.1840080532 CASPubMedWeb of Science®Google Scholar 37 Valla D, Poynard T, Bercoff E, Bataille C, Goldfarb G, LeBrec D. Le syndrome d'hypercinésie circulatoire systémique chez les malades atteints de cirrhose: relations avec l'insuffisance hépatocellulaire et l'hypertension portale. Gastroenterol Clin Biol 1984; 8: 321–324. CASPubMedWeb of Science®Google Scholar 38 Braillon A, Cales P, Valla D, Gandy D, Geoffray P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic hemodynamics and in response to propranolol in patients with cirrhosis. Gut 1986; 27: 1204–1209. 10.1136/gut.27.10.1204 PubMedWeb of Science®Google Scholar 39 Cohn JD, Greenspan M, Goldstein CR, Gudwin AL, Siegel OLT, Del Guercico LRM. Arteriovenous shunting in high cardiac output shock syndromes. Surg Gynecol Obstet 1968; 127: 282–288. CASPubMedWeb of Science®Google Scholar 40 Gunning TC, Paulsen AW, Brajtbord D, Goldstein RM, Ramsey MAE. Intraoperative systemic and hepatic hemodynamics associated with fulminant hepatic failure: comparison with chronic end-stage liver disease. Transplant Proc 1991; 23: 1569. CASPubMedWeb of Science®Google Scholar 41 Even P, Nicollo F, Benhamou JP, Fauvert R. La débit cardiaque au cours des maladies du foie: effets de l'anastomose porto-cave et des diurétiques. Rev Int Hepatol 1966; 16: 955–983. CASPubMedGoogle Scholar 42 Reichle FA, Owen OE. Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts. Ann Surg 1979; 190: 523–533. 10.1097/00000658-197910000-00012 CASPubMedWeb of Science®Google Scholar 43 Henderson JM, Mackay GJ, Hooks M, Chezmar JL, Galloway JR, Dodson TF, Kutner MH. High cardiac output of advanced liver disease persists after orthotopic liver transplantation. Hepatology 1991; 15: 258–262. 10.1002/hep.1840150214 Web of Science®Google Scholar 44 Hadengue A, Lebrec D, Moreau R, Sogni P, Durand F, Gaudin C, Bernuau J, et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 1993; 17: 175–178. 10.1002/hep.1840170202 CASPubMedWeb of Science®Google Scholar 45 Navasa M, Feu F, Garciá-Pagán JC, Jiménez W, Llach J, Rimola A, Bosch J, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993; 17: 355–360. 10.1002/hep.1840170302 CASPubMedWeb of Science®Google Scholar 46 Henderson JM. Abnormal splanchnic and systemic hemodynamics of end-state liver disease: what happens after liver transplantation? Hepatology 1993; 17: 515–516. 10.1002/hep.1840170323 Web of Science®Google Scholar 47 Chezmar JL, Redvanly RD, Nelson RL, Henderson JM. Persistence of portal systemic collaterals and splenomegaly on CT scan after orthotopic liver transplantation. AJR Am J Roentgenol 1992; 159: 317–320. 10.2214/ajr.159.2.1632346 PubMedWeb of Science®Google Scholar 48 Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989; 151: 530–535. CASPubMedWeb of Science®Google Scholar Citing Literature Volume20, Issue5November 1994Pages 1356-1358 ReferencesRelatedInformation
Referência(s)